The 2025 BioPharma & MedTech IPO Landscape
By Patrick Nugent
With Highlights from the JP Morgan Healthcare Conference To understand the current IPO landscape of BioPharma and MedTech, let’s go straight to the data: There were 15 IPOs globally in 2024; 10 in 2023, and 25 in 2022 for MedTech companies. MedTech IPO activity peaked in 2021 with 61 companies…Read More
Read MoreFireside Chat: In Conversation with Jennifer Cho, FLG’s Next Managing Partner
By Laureen DeBuono
FLG’s Managing Partner Laureen DeBuono will complete her highly successful and transformational five-year term as Managing Partner on February 1, 2025. In this fireside chat, Laureen interviews her successor Jennifer Cho, who was unanimously voted to take on the role. Explore Jennifer’s background, how she grew her career to lead…Read More
Read More2024 Financial Trends and Outlook for 2025: Financial Discipline Will Be the Rule
By Laureen DeBuono
This year, we at FLG Partners celebrated our 20th Anniversary in business as the premier interim CFO and BOD advisory services firm in the United States. We thank our clients, referral partners, and industry colleagues who have helped us meet our business objectives. We are so grateful. Through these partnerships,…Read More
Read MoreNegotiating Software Agreements: Best Practices for CFOs
By Stephanie Roberts
Utilizing software for overall efficiency and growth company-wide is critical to company-wide success. While software is essential for business growth, so is the ability to negotiate and maintain the costs of these services. Over the last few years, I’ve been challenged by high software expenses and a lack of flexibility…Read More
Read More